{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:17:48Z","timestamp":1789762668047,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21778011"],"award-info":[{"award-number":["21778011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003599"],"award-info":[{"award-number":["82003599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192015"],"award-info":[{"award-number":["7192015"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115631","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T13:08:03Z","timestamp":1696511283000},"page":"115631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability"],"prefix":"10.1016","volume":"167","author":[{"given":"Duo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-7340","authenticated-orcid":false,"given":"Rugang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.biopha.2023.115631_bib1","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/cr941192h","article-title":"A critical appraisal of the evolution of N-nitrosoureas as anticancer drugs","volume":"97","author":"Gnewuch","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2023.115631_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2014.01.010","article-title":"Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors","volume":"67\u201368","author":"Bhujbal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/tx950097g","article-title":"Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity","volume":"9","author":"Chen","year":"1996","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1988.68.1.0001","article-title":"Chemotherapy for malignant gliomas","volume":"68","author":"Kornblith","year":"1988","journal-title":"J. Neurosurg."},{"issue":"11","key":"10.1016\/j.biopha.2023.115631_bib6","first-page":"1876","article-title":"Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962","volume":"25","author":"De Vita","year":"1965","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115631_bib7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1378\/chest.107.5.1355","article-title":"Late carmustine lung fibrosis. Age at treatment may influence severity and survival","volume":"107","author":"O'Driscoll","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2023.115631_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0079-6603(08)60879-X","article-title":"Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase","volume":"51","author":"Pegg","year":"1995","journal-title":"Prog. Nucleic Acid. Res. Mol. Biol."},{"issue":"14","key":"10.1016\/j.biopha.2023.115631_bib9","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1073\/pnas.87.14.5368","article-title":"Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents","volume":"87","author":"Dolan","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.biopha.2023.115631_bib10","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1158\/1078-0432.CCR-05-0060","article-title":"Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma","volume":"11","author":"Gajewski","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/14728222.11.3.349","article-title":"S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy","volume":"11","author":"Juillerat","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.biopha.2023.115631_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0002-9440(10)64025-4","article-title":"Glomeruloid microvascular proliferation orchestrated by VPF\/VEGF: a new world of angiogenesis research","volume":"158","author":"Brat","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.biopha.2023.115631_bib14","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1158\/1078-0432.CCR-07-0478","article-title":"Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104","volume":"13","author":"Patterson","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.115631_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bcp.2011.02.019","article-title":"KS900: a hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O(6)-alkylguanine-DNA alkyltransferase in neoplastic cells","volume":"81","author":"Baumann","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115631_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112338","article-title":"Development and biological evaluation of AzoBGNU: a novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity","volume":"144","author":"Liu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115631_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/dmd.112.048322","article-title":"Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma","volume":"41","author":"Agarwal","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.biopha.2023.115631_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biopha.2023.115631_bib20","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2023.115631_bib21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12325-018-0707-z","article-title":"Safety of polysorbate 80 in the oncology setting","volume":"35","author":"Schwartzberg","year":"2018","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2023.115631_bib22","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.7150\/thno.23734","article-title":"Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115631_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/IJN.S236922","article-title":"Rhynchophylline Loaded-mPEG-PLGA Nanoparticles coated with tween-80 for preliminary study in alzheimer's disease","volume":"15","author":"Xu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115631_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125657","article-title":"Hypoxia and CD44 receptors dual-targeted nano-micelles with AGT-inhibitory activity for the targeting delivery of carmustine","volume":"246","author":"Li","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2008.03.009","article-title":"Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles","volume":"70","author":"Wilson","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1022604120952","article-title":"Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles","volume":"20","author":"Kreuter","year":"2003","journal-title":"Pharm. Res."},{"issue":"41","key":"10.1016\/j.biopha.2023.115631_bib27","doi-asserted-by":"crossref","first-page":"27465","DOI":"10.1021\/acsami.6b05572","article-title":"T7 peptide-functionalized PEG-PLGA micelles loaded with carmustine for targeting therapy of glioma","volume":"8","author":"Bi","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","article-title":"Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115631_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2005.03.005","article-title":"Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies","volume":"105","author":"Xie","year":"2005","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.biopha.2023.115631_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2009.09.020","article-title":"Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals","volume":"141","author":"Ying","year":"2010","journal-title":"J. Control Release"},{"issue":"38","key":"10.1016\/j.biopha.2023.115631_bib31","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1016\/j.biomaterials.2013.09.034","article-title":"Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM","volume":"34","author":"Florczyk","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2023.115631_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0009-9236(03)00222-4","article-title":"Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins","volume":"74","author":"Loos","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2023.115631_bib34","first-page":"445","article-title":"Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles","volume":"6","author":"Tian","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biopha.2023.115631_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejpb.2004.11.009","article-title":"Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides","volume":"60","author":"Yilmaz","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.biopha.2023.115631_bib37","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1039\/C6CP08506G","article-title":"Swollen micelles and alcohol-surfactant co-adsorption: structures and mechanisms from liquid- and solid-state (1)H-(1)H NMR spectroscopy","volume":"19","author":"Totland","year":"2017","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"24","key":"10.1016\/j.biopha.2023.115631_bib38","doi-asserted-by":"crossref","first-page":"20385","DOI":"10.1021\/acsami.7b02606","article-title":"Specifically Increased Paclitaxel Release in Tumor and Synergetic Therapy by a Hyaluronic Acid-Tocopherol Nanomicelle","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2023.115631_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2021.04.035","article-title":"Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer","volume":"334","author":"Long","year":"2021","journal-title":"J. Control Release"},{"issue":"10","key":"10.1016\/j.biopha.2023.115631_bib40","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1139\/cjpp-2019-0092","article-title":"Comparison of hypoxic effects induced by chemical and physical hypoxia on cardiomyocytes","volume":"97","author":"Zhao","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115631_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0045-6535(99)00226-X","article-title":"Non-enzymatic reduction of azo dyes by NADH","volume":"40","author":"Nam","year":"2000","journal-title":"Chemosphere"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2023.115631_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0169-409X(98)00088-X","article-title":"The blood-brain barrier efflux transporters as a detoxifying system for the brain","volume":"36","author":"Terasaki","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115631_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2013.11.018","article-title":"Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound","volume":"174","author":"Deng","year":"2014","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10611860500071292","article-title":"Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns","volume":"13","author":"Goppert","year":"2005","journal-title":"J. Drug Target"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115631_bib45","first-page":"1","article-title":"Polysorbate 80 coated poly (varepsilon-caprolactone)-poly (ethylene glycol)-poly (varepsilon-caprolactone) micelles for paclitaxel delivery","volume":"434","author":"Wang","year":"2012","journal-title":"Int J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.115631_bib46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3109\/10717544.2014.926574","article-title":"Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies","volume":"23","author":"Jain","year":"2016","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2023.115631_bib48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/A:1016033702220","article-title":"The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system","volume":"13","author":"Nerurkar","year":"1996","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1992.217","article-title":"Reversal of multidrug resistance by surfactants","volume":"66","author":"Woodcock","year":"1992","journal-title":"Br. J. Cancer"},{"issue":"6927","key":"10.1016\/j.biopha.2023.115631_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.biopha.2023.115631_bib51","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.1021\/acsami.6b01680","article-title":"Transport mechanism of coumarin 6 nanocrystals with two particle sizes in MDCKII monolayer and larval zebrafish","volume":"8","author":"Miao","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.biopha.2023.115631_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112342","article-title":"The molecular and phenotypic basis of the glioma invasive perivascular niche","volume":"18","author":"Diksin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2023.115631_bib53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jnci\/djr224","article-title":"Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion","volume":"103","author":"Edwards","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.biopha.2023.115631_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121186","article-title":"Three-dimensional spheroids as in vitro preclinical models for cancer research","volume":"12","author":"Pinto","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2023.115631_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13046-020-01583-1","article-title":"Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models","volume":"39","author":"Bhattacharya","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.115631_bib56","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jbm.b.33304","article-title":"Three-dimensional constructs using hyaluronan cell carrier as a tool for the study of cancer stem cells","volume":"103","author":"Martinez-Ramos","year":"2015","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:19:32Z","timestamp":1776460772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223014294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":56,"alternative-id":["S0753332223014294"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115631","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115631"}}